Prometheus Biosciences News

RXDXDelisted Stock  USD 199.92  0.24  0.12%   
Slightly above 55% of Prometheus Biosciences' investor base is interested to short. The analysis of current outlook of investing in Prometheus Biosciences suggests that many traders are impartial regarding Prometheus Biosciences' prospects. Prometheus Biosciences' investing sentiment can be driven by a variety of factors including economic data, Prometheus Biosciences' earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
Global markets live Adobe, Eli Lilly, Nasdaq, Intel, UBS... - Marketscreener.com
Google News at Macroaxis
over a year ago at www.macroaxis.com         
Disposition of 178098 shares by Mark McKenna of Prometheus Biosciences subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
How Has Merck Stock Performed During The 2022-23 Inflation Shock - Trefis
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Boxer Capital LLC Boosts Stock Position in Prometheus Biosciences, Inc.
news
over a year ago at thelincolnianonline.com         
Prometheus Biosciences Sees Large Volume Increase
news
over a year ago at prnewswire.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates RXDX, RADI, FOCS
prnewswire News
over a year ago at www.macroaxis.com         
Exercise or conversion by Mark McKenna of 122528 shares of Prometheus Biosciences subject to Rule 16...
Macroaxis News
over a year ago at news.google.com         
RXDX Stock Alert Halper Sadeh LLC Is Investigating Whether the Sale of Prometheus Biosciences, Inc. ...
Google News at Macroaxis
over a year ago at prnewswire.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates RXDX, MDWT, RUTH
prnewswire News
over a year ago at news.google.com         
PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, L...
Google News at Macroaxis
over a year ago at www.macroaxis.com         
Acquisition by Papa Joseph C of 2278 shares of Prometheus Biosciences subject to Rule 16b-3
Macroaxis News
over a year ago at finance.yahoo.com         
What Makes Prometheus Biosciences an Attractive Investment Choice?
Yahoo News
over a year ago at simplywall.st         
We Think Prometheus Biosciences Can Afford To Drive Business Growth
Simply Wall St News at Macroaxis
over a year ago at news.google.com         
In April 2023, the healthcare industry reported 62 deals worth 22.7 bn GlobalData - Express Pharma
Google News at Macroaxis
over a year ago at finance.yahoo.com         
Prometheus Biosciences, Inc. is a Great Momentum Stock Should You Buy?
Yahoo News
Far too much social signal, news, headlines, and media speculation about Prometheus Biosciences that are available to investors today. That information is available publicly through Prometheus media outlets and privately through word of mouth or via Prometheus internal channels. However, regardless of the origin, that massive amount of Prometheus data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Prometheus Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Prometheus Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Prometheus Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Prometheus Biosciences alpha.

Prometheus Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Why Madrigal Pharmaceuticals Stock Gained 20 percent This Week
04/20/2023
2
Cocrystal Pharma Appoints Pharma Industry Veteran Fred Hassan to its Board of Directors - Marketscreener.com
04/24/2023
3
Ieq Capital LLC Sells off 35.3 percent of Holding in Prometheus ... - Best Stocks
04/28/2023
4
Prometheus Biosciences, Inc. Reports Q1 Loss, Tops Revenue Estimates
05/09/2023
5
Prometheus Biosciences, Inc. is a Great Momentum Stock Should You Buy
05/12/2023
6
We Think Prometheus Biosciences Can Afford To Drive Business Growth
05/17/2023
7
PROMETHEUS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana Kahn Swick Foti, LLC Investigates Adequacy of Price and Process in Proposed Sa...
05/22/2023
8
Exercise or conversion by Mark McKenna of 122528 shares of Prometheus Biosciences subject to Rule 16b-3
06/02/2023
9
Boxer Capital LLC Boosts Stock Position in Prometheus Biosciences, Inc.
06/13/2023
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Consideration for investing in Prometheus Stock

If you are still planning to invest in Prometheus Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Prometheus Biosciences' history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope